Functional involvement of PHOSPHO1 in matrix vesicle-mediated skeletal mineralization
- PMID: 17227223
- DOI: 10.1359/jbmr.070108
Functional involvement of PHOSPHO1 in matrix vesicle-mediated skeletal mineralization
Abstract
PHOSPHO1 is a phosphatase highly expressed in bone. We studied its functional involvement in mineralization through the use of novel small molecule inhibitors. PHOSPHO1 expression was present within matrix vesicles, and inhibition of enzyme action caused a decrease in the ability of matrix vesicles to calcify.
Introduction: The novel phosphatase, PHOSPHO1, belongs to the haloacid dehalogenase superfamily of hydrolases and is capable of cleaving phosphoethanolamine (PEA) and phosphocholine to generate inorganic phosphate. Our aims in this study were to examine the expression of PHOSPHO1 in murine mineralizing cells and matrix vesicles (MV) and to screen a series of small-molecule PHOSPHO1-specific inhibitors for their ability to pharmacologically inhibit the first step of MV-mediated mineralization.
Materials and methods: q-PCR and immunohistochemistry were used to study the expression and localization profiles of PHOSPHO1. Inhibitors of PHOSPHO1's PEA hydrolase activity were discovered using high-throughput screening of commercially available chemical libraries. To asses the efficacy of these inhibitors to inhibit MV mineralization, MVs were isolated from TNAP-deficient (Akp2(-/-)) osteoblasts and induced to calcify in their presence.
Results: q-PCR revealed a 120-fold higher level of PHOSPHO1 expression in bone compared with a range of soft tissues. The enzyme was immunolocalized to the early hypertrophic chondrocytes of the growth plate and to osteoblasts of trabecular surfaces and infilling primary osteons of cortical bone. Isolated MVs also contained PHOSPHO1. PEA hydrolase activity was observed in sonicated MVs from Akp2(-/-) osteoblasts but not intact MVs. Inhibitors to PHOSPHO1 were identified and characterized. Lansoprazole and SCH202676 inhibited the mineralization of MVs from Akp2(-/-) osteoblasts by 56.8% and 70.7%, respectively.
Conclusions: The results show that PHOSPHO1 localization is restricted to mineralizing regions of bone and growth plate and that the enzyme present within MVs is in an active state, inhibition of which decreases the capacity of MVs to mineralize. These data further support our hypothesis that PHOSPHO1 plays a role in the initiation of matrix mineralization.
Similar articles
-
Inhibition of PHOSPHO1 activity results in impaired skeletal mineralization during limb development of the chick.Bone. 2010 Apr;46(4):1146-55. doi: 10.1016/j.bone.2009.12.018. Epub 2010 Jan 4. Bone. 2010. PMID: 20053388 Free PMC article.
-
Skeletal Mineralization Deficits and Impaired Biogenesis and Function of Chondrocyte-Derived Matrix Vesicles in Phospho1(-/-) and Phospho1/Pi t1 Double-Knockout Mice.J Bone Miner Res. 2016 Jun;31(6):1275-86. doi: 10.1002/jbmr.2790. Epub 2016 May 17. J Bone Miner Res. 2016. PMID: 26773408 Free PMC article.
-
Pharmacological inhibition of PHOSPHO1 suppresses vascular smooth muscle cell calcification.J Bone Miner Res. 2013 Jan;28(1):81-91. doi: 10.1002/jbmr.1733. J Bone Miner Res. 2013. PMID: 22887744 Free PMC article.
-
The role of phosphatases in the initiation of skeletal mineralization.Calcif Tissue Int. 2013 Oct;93(4):299-306. doi: 10.1007/s00223-012-9672-8. Epub 2012 Nov 27. Calcif Tissue Int. 2013. PMID: 23183786 Free PMC article. Review.
-
PLA2 and ENPP6 may act in concert to generate phosphocholine from the matrix vesicle membrane during skeletal mineralization.FASEB J. 2018 Jan;32(1):20-25. doi: 10.1096/fj.201700521R. Epub 2017 Sep 1. FASEB J. 2018. PMID: 28864658 Review.
Cited by
-
Reduced phosphorus intake throughout gestation and lactation of sows is mitigated by transcriptional adaptations in kidney and intestine.BMC Genomics. 2020 Sep 11;21(1):626. doi: 10.1186/s12864-020-07049-0. BMC Genomics. 2020. PMID: 32917128 Free PMC article.
-
Kinetic analysis of substrate utilization by native and TNAP-, NPP1-, or PHOSPHO1-deficient matrix vesicles.J Bone Miner Res. 2010 Apr;25(4):716-23. doi: 10.1359/jbmr.091023. J Bone Miner Res. 2010. PMID: 19874193 Free PMC article.
-
Identification of novel regulators of osteoblast matrix mineralization by time series transcriptional profiling.J Bone Miner Metab. 2014 May;32(3):240-51. doi: 10.1007/s00774-013-0493-2. Epub 2013 Aug 8. J Bone Miner Metab. 2014. PMID: 23925391
-
Increased PHOSPHO1 expression mediates cortical bone mineral density in renal osteodystrophy.J Endocrinol. 2022 Aug 12;254(3):153-167. doi: 10.1530/JOE-22-0097. Print 2022 Sep 1. J Endocrinol. 2022. PMID: 35900032 Free PMC article.
-
Sphingolipid metabolism and its role in the skeletal tissues.Cell Mol Life Sci. 2015 Mar;72(5):959-69. doi: 10.1007/s00018-014-1778-x. Epub 2014 Nov 26. Cell Mol Life Sci. 2015. PMID: 25424644 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous